Related Experiment Videos
Efficacy of cyclosporin A for idiopathic pulmonary fibrosis
M Fukazawa1, M Kawano, S Hisano
1Department of Paediatrics, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Insights
Idiopathic pulmonary fibrosis (IPF) in a child was treated with cyclosporin A (Cs A). This immunosuppressant therapy successfully normalized blood oxygen levels and resolved symptoms, marking a potential new treatment for pediatric IPF.
Area of Science:
- Pediatric Pulmonology
- Immunology
- Pharmacology
Background:
- Idiopathic pulmonary fibrosis (IPF) is a rare and progressive lung disease.
- Pediatric IPF presents unique diagnostic and therapeutic challenges.
- Standard treatments often have limited efficacy or significant side effects in children.
Observation:
- An 11-year-old girl presented with severe dyspnea and cyanosis, diagnosed with IPF.
- High-dose corticosteroid therapy provided only partial oxygenation support and could not be reduced.
- Concomitant azathioprine with prednisolone worsened the patient's condition.
Findings:
- Introduction of cyclosporin A (Cs A) alongside prednisolone led to normalization of blood oxygen levels (PaO2) within one month.
- Prednisolone was successfully tapered off within six months.
- The patient remained symptom-free for two years on continuous Cs A therapy.
Implications:
- Cyclosporin A (Cs A) demonstrates significant efficacy in treating pediatric idiopathic pulmonary fibrosis (IPF).
- This case suggests Cs A as a promising alternative or adjunctive therapy for severe pediatric IPF.
- Successful management with Cs A may offer a new therapeutic avenue, improving long-term outcomes for affected children.
Abstract:
In an 11-year-old girl with severe dyspnoea and cyanosis, idiopathic pulmonary fibrosis (IPF) was diagnosed. The PaO2 of blood could be maintained between 50 mm Hg and 70 mm Hg with a high dose pulse corticosteroid therapy, although this dose could not be reduced. Azathioprine in addition to prednisolone provoked deterioration. Twelve weeks after admission, cyclosporin A (Cs A), a known immunosuppressant, was started together with prednisolone. The PaO2 reverted to normal within 1 month and prednisolone could be tapered off within 6 months. Two years after admission, the patient is free of symptoms on continuous Cs A therapy. This case seems to be the first case successfully treated with Cs A.